|
Article: JAMA meta-analysis of Placebo response and cannabis based therapies for pain
|
|
2
|
1454
|
December 3, 2022
|
|
Test-retest reliability and responsiveness of health status questionnaires
|
|
3
|
1349
|
November 19, 2022
|
|
Bayesian sample size calculation
|
|
1
|
4632
|
January 18, 2021
|
|
Guidelines for Covariate Adjustment in RCTs
|
|
62
|
35295
|
October 9, 2022
|
|
Language regarding confidence in "negative" results
|
|
0
|
961
|
October 5, 2022
|
|
Sample size linear regression
|
|
3
|
3391
|
September 18, 2022
|
|
Can I conduct an exploratory cross-over study on data originally collected in a clinical trial?
|
|
0
|
871
|
September 7, 2022
|
|
Cdisc in academia
|
|
1
|
1382
|
September 7, 2022
|
|
From observed event rates to event rate per anno and 5-year risk
|
|
1
|
1343
|
August 31, 2022
|
|
How can the change in exposure be taken into account in the survival analysis?
|
|
1
|
1054
|
August 12, 2022
|
|
Inventory/Cost of Goods
|
|
1
|
2125
|
July 9, 2022
|
|
Predicting rare outcomes
|
|
8
|
5083
|
June 26, 2022
|
|
Discussion on reconstructing data
|
|
4
|
4639
|
June 22, 2022
|
|
Article(s): Coffee Benefits and Continuous vs. Categorical Variable Analysis
|
|
3
|
2655
|
June 19, 2022
|
|
Study Design for Subjective Multinomial Outcome
|
|
7
|
3743
|
June 6, 2022
|
|
What type of study design can best describe this Study?
|
|
0
|
1710
|
June 2, 2022
|
|
Should adverse effects be adjusted for multiple comparisons?
|
|
4
|
3743
|
May 24, 2022
|
|
Predictive modelling of crossover trial with a binary outcome and four interventions
|
|
0
|
1570
|
May 12, 2022
|
|
Prospective OR Retrospective Cohort Study?
|
|
3
|
5139
|
May 8, 2022
|
|
What are the decision rules for concluding on the effectiveness of the treatment when intermediate analyses are planned?
|
|
6
|
2709
|
May 8, 2022
|
|
Is logistic regression or survival analysis most appropriate in this case?
|
|
1
|
2293
|
April 28, 2022
|
|
Statistical power estimation for a time-dependent covariate in Cox (proportional hazards) regression
|
|
0
|
2008
|
April 19, 2022
|
|
Methodology: Benefit Risk Assessment when Risk and Benefit are only observed in different timing
|
|
5
|
2153
|
April 18, 2022
|
|
Do we need a research hypothesis for developing a clinical prediction model?
|
|
7
|
3228
|
April 9, 2022
|
|
Article: Going from evidence to recommendations: Can GRADE get us there?
|
|
0
|
2146
|
April 3, 2022
|
|
Exemplary QOL analyses that avoid change-from-baseline blunders?
|
|
22
|
16070
|
March 10, 2022
|
|
Interesting Talk on Dichotomization
|
|
9
|
3409
|
March 2, 2022
|
|
Outcome dispersion and reduction of outliers as a primary outcome in clinical RCT?
|
|
3
|
2473
|
February 24, 2022
|
|
Understanding "BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting]"
|
|
0
|
2036
|
January 18, 2022
|
|
RCT - baseline measures and group x time interaction without main effect for group?
|
|
6
|
6558
|
January 1, 2022
|